Download now
← Case studies
2022-03-18Regulations

Quality System Upgrade to Meet EU MDR and EU IVDR

Case study on Quality System Upgrade to Meet EU MDR and EU IVDR.

Learn how USDM Life Sciences helped a large medical device manufacturer upgrade their Quality System by revising 400 SOPs, generating CND codes for EUDAMED submissions, and easing concerns for how to plan for recall items.

Meeting MDR Requirements

The company needed a submission process to get all existing devices recertified under the MDR requirements which include re-certification of the notified bodies, new submission requirements including new clinical, evidence, reasoning (CER) forms, new post-marketing safety analysis, and reporting requirements, and changes to the device technical files and dossiers.

The Situation
  • Large Medical Device Manufacturer
  • Products in multiple countries
  • The company's QMS system and 400 SOPs required review and revisions
  • CND codes for EUDAMED submission were needed
  • The company was concerned on how to plan for recalls by item
The Solution
  • USDM met with lead regulatory and quality executives to review the process and sequence of activities
  • USDM inventoried all policies and procedures that were affected by EU MDR and reviewed all necessary documents
  • USDM also reviewed other policies and procedures to ensure they were not relevant to EU MDR initiatives
  • USDM then assigned select regulatory consultants, based on skill set and experience, to review and redline policies and procedures in their respective area of expertise
  • All proposed revisions were reviewed with the relevant regulatory and quality managers
  • USDM also provided support for the SOPs submission processes for device recertification

The Results

  • < 8 month timeline to establish Quality System to meet EU MDR requirements​
  • $3B in revenue risk reduction across EU​
  • Ready to submit data to European Database on Medical Devices (EUDAMED)

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

  • Workflow inventory and risk classification
  • Business value and readiness scoring
  • FDA CSA + EU AI Act + ISO 42001 gap analysis
  • Prioritized 90-day roadmap by impact, risk, and effort

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.